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Humans have evolved in an environmental and social context that enabled reliable 
transmissiosn and dispersal of symbionts, accompanied by appropriate nutritional support. 
However, recent changes in lifestyles, diet and social interactions have altered these 
metacommunity processes, disrupted the human microbiome and, as a consequence, increased risk 
of immune-mediated diseases such as allergy and asthma (1, 2).  The mechanisms that mediate 
host-microbe communication are highly sophisticated and are being intensely investigated. One 
microbial-dietary interaction that has important immunoregulatory consequences for the host is the 
fermentation of dietary fibers by commensal microbes in the gut, resulting in the generation of 
short-chain fatty acids (SCFAs), which include acetate, propionate and butyrate (3, 4). SCFAshave 
been shown to increase Treg numbers and effectiveness, reduce effector T cell activity, promote B 
cell IgA production, support maturation and maintenance of tolerogenic dendritic cells, influence 
bone marrow haematopoiesis, improve epithelial barrier function and modulateinnate lymphoid 
cellactivation (5). SCFAs can mediate their effects via multiple mechanisms that include binding 
to metabolite-sensing G-protein coupled receptors (GPCRs), such as GPR41, GPR43 and 
GPR109A, or by inhibiting the activity of chromatin modifying enzymes (such as histone 
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However, the effects of these metabolites on the activation of key effector cells in allergy 
and asthma, specifically mast cells, has been poorly characterised. In this issue, Folkerts and 
colleagues investigate the effects and underlying mechanisms for SCFAs modulation of mast cell 
activation (6). Firstly, they demonstrated that butyrate inhibited IgE- and allergen-induced airway 
contraction using precision cut lung slices (PCLS) from the lower airways of guinea pigs, which 
was associated with reduced histamine release. In addition, butyrate and propionate, but not 
acetate, inhibited IgE- and non-IgE-mediated mast cell activation using murine primary bone-
marrow-derived mast cells and human peripheral blood mononuclear cell-derived mast cells 
(Figure 1). Using mast cell from GPCR knock-out animals, they showed that inhibition of mast 
cell activity was independent of GPR41 and GPR43. Nuclear peroxisome-activated receptors 
(PPARs) were also not required for the observed effects. However, butyrate (and to a lesser extent 
propionate) attenuated HDAC activity in both murine and human mast cells, suggesting that 
SCFAs may regulate mast cell degranulation via epigenetic modifications. Indeed, a detailed 
evaluation of the mast cell transcriptome following exposure to butyrate described altered 
expression of genes associated with mast cell activation, inflammatory responses and cytokine 
signalling. The authors also demonstrated that butyrate exposure substantially impacts global mast 
cell histone acetylation patterns, using ChIP-Seq. Importantly, the authors identified butyrate-
induced deacetylation at the transcription start sites of genes critical for FcRI-mediated mast cell 
activation, such as Bruton’s tyrosine kinase (BTK), spleen tyrosine kinase (SYK) and Linker for 
Activation of T cells (LAT).
The findings of the present study that identify butyrate and propionate, but not acetate, as 
modulators of mast cell activity correlates well with a recent study that associated high faecal 
levels of butyrate and propionate, but not acetate, with reduced risk of allergies and asthma in 
children (7). Due to their location in the gut and vascularized tissues, mast cells can be exposed to 
high concentrations of SCFAs coming from within the gastrointestinal tract.In addition, the 
present study suggests that SCFAs may modulate immune activity in a cell-type specific manner. 
GPCRs have previously been shown to be required for certain SCFAs effects on dendritic cells 
and lymphocytes (8), but these receptors do not seem to be required for inhibition of mast cell 
degranulation.Rather, epigenetic regulation via HDAC inhibition seems to be required for control 
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In summary, this study adds to a growing body of literature that supports the 
immunomodulatory role of SCFAs in maintaining a tolerogenic mucosal environment and 
protecting against allergic disorders. Overall, these findings highlight the potential for using 
targeted manipulations of the gut microbiome and its metabolic functions in promoting immune 
health.However, the optimal prevention or treatment strategies involving SCFAs in humans have 
yet to be defined, but could include administration of fibers, synbiotics or the SCFAs themselves. 
In addition, the inclusionof SCFAs within immunotherapy protocols needs to be further explored 
in human clinical studies.
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